7th Annual Liquid Biopsy for Precision Oncology Summit

Kongressthemen
The 7th Liquid Biopsy for Precision Oncology Summit returns as the largest and most comprehensive forum for all stakeholders in the field to tap into the promising opportunities that revolutionize the entire cancer patient care continuum from early translation all the way through to clinical development and commercialization.

Expect exclusive data from KOLs on the most recent developments in the utilization of liquid biopsies for early detection, prognosis and treatment.

Wissenschaftliche Fach-Gesellschaft
Hanson Wade

Anmerkungen
Speakers: Ahmet Zehir, Executive Director- Precision Medicine and Diagnostic Innovation, AstraZeneca, Alessandra Cesano, Chief Medical Officer, ESSA Pharma, Andrea Stevens, Director - Precision Medicine Access Strategy, Janssen and More

https://go.evvnt.com/1420377-2?pid=4832

Frau Anita Kelemen